Please assess the completion status of the following clinical trial:

Trial Title: Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
INCLUSION CRITERIA:~* Histologically or cytologically confirmed non-hematopoietic malignancy within the past 5 years~  * If histologic proof of malignancy is from \> 5 years ago, then a more recent pathological confirmation is required (e.g., from systemic metastatic or brain metastasis)~ * Patients with metastasis of unknown primary tumor are permitted~* Measurable brain metastasis outside a 5-mm margin around either hippocampus on gadolinium contrast-enhanced MRI obtained within the past 30 days~* Have not been or will not be treated with stereotactic radiosurgery (SRS) or surgical resection~  * These treatment options are allowed only at relapse~* Patients who have brain metastases at initial presentation allowed and do not need to demonstrate 3 months of stable scans~* At least 1 week since open biopsy~* Karnofsky performance status 70-100%~* Fertile patients must use effective contraception~* Negative pregnancy test 2 weeks or less prior to study entry~* Patients must be English proficient, with patients who speak English as a second language eligible~EXCLUSION CRITERIA:~* Small cell lung cancer or germ cell malignancy~* Leptomeningeal metastases~* Non-small cell lung cancer-associated brain metastases with ≥ 2 organ sites of extracranial metastases~* Radiologic evidence of hydrocephalus~* Serum creatinine \> 1.4 mg/dL within 30 days prior to study entry~* Pregnant or nursing~* Contraindication to MRI imaging such as implanted metal devices or foreign bodies or severe claustrophobia~* Severe, active co-morbidity including any of the following:~  * Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months~ * Transmural myocardial infarction within the past 6 months~ * Acute bacterial or fungal infection requiring intravenous antibiotics~ * Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects~ * Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy~ * Uncontrolled, clinically significant cardiac arrhythmias~* Prior radiotherapy to the brain~* Plan for chemotherapy or targeted therapies during WBRT or during the subsequent 7 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- WBRT with Hippocampal Avoidance (Type: OTHER): Whole brain radiotherapy (WBRT) with hippocampal avoidance using intensity-modulated radiation therapy (IMRT)

Based on this trial design, predict the completion outcome and termination type (if applicable).